Not exact matches
The Company focuses on discovering and developing small molecule drugs directed
against tumor and immune
cell targets that control key metabolic pathways in the tumor microenvironment.
Jacob's team has transplanted the back - up or «alternative» respiratory machinery from the mitochondria of lower organisms to human
cells, showing that it can protect
against pathological stresses, and even lethal poisons like cyanide, that
target the mitochondria.
«It's blue sky, but we can certainly envision making different inhibitors of channels with monobodies, which could perhaps be
targeted against harmful
cells and microorganisms.»
Drugs that
targeted the RAS pathway showed little activity
against the tumor
cells.
Wapner's narrative follows developments from the recognition of a chromosomal abnormality in cancer
cells to the production of a
targeted drug
against what had been a lethal leukemia.
In human donor
cells and mouse experimental models, the researchers demonstrated that TSLP specifically
targeted neutrophils — white blood
cells that constitute the first line of defense
against bacterial infections.
As with innate immunity, the adaptive immune system — the T
cells and antibodies produced by B
cells that
target specific molecules on invading
cells — contributes to pathology or may also fight
against it.
Co-senior study investigator and cancer biologist Iannis Aifantis, PhD, says the study offers the first evidence that «drugs
targeting and disrupting leukemia
cells» microenvironment — or what goes on around them — could prove effective
against the disease.»
For patients, down the road Dr. Ohashi envisions a new era of combined therapies to simultaneously
target and kill these suppressive
cells while augmenting the immune response
against cancer.
By tracking and understanding which host
cell pathways are manipulated by these T. gondii proteins, scientists can identify potential new
targets to develop more effective therapies
against highly aggressive solid tumors.
They prepared a similar weapon
against liver cancer by piggybacking rhenium 18 on antibodies that
target HBx, a viral antigen made by cancerous liver
cells.
The
targets of these drugs were not know to be present in cancer
cells and therefore no one had considered the possibility that these drugs might be effective
against aggressive cancer types, says Professor Ivaska.
HIV's favorite
target is the CD4 T
cell, which orchestrates our entire immune response
against the disease.
Pyrethroids, the main class of pesticides used
against bedbugs today,
targets sodium channels in bedbug
cells, just like DDT.
Once in the lymph nodes, these vaccines can stimulate production of huge numbers of T
cells against the vaccine
target.
Such hybrid carriers have several advantages: low toxicity, efficient intracellular delivery and protection of siRNA
against premature degradation prior to reaching the
target cells.
Scientists from Tomsk Polytechnic University together with their colleagues from St. Petersburg and London have elaborated a new approach to deliver anti-viral RNAi to
target cells against H1N1 influenza virus infection.
Scientists were able to selectively
target the
cells that cause autoimmune disease by dampening down their aggression
against the body's own tissues while converting them into
cells capable of protecting
against disease.
«This is because the stress led to poor function
against the cancer by T -
cells, which are very important in the immune system's control and surveillance of tumours and are a major
target in many immunotherapy treatments.»
Therapies based on immune
cells, which
target particular tumor molecules, are more specific, but they are not effective
against a variety of tumors.
A T -
cell marker panel that can identify subsets of tumor - associated T -
cells allows scientists to identify and
target subpopulations of T -
cells playing unique roles in the immune response
against a tumor.
Neoantigens are molecules on
cell's surfaces that are produced by DNA mutations that are present in cancer
cells but not in normal
cells, making neoantigens ideal
targets for immune therapy
against cancer, say the scientists.
An alternative approach, most common for anti-infectives, is to use compounds («phenotypic inhibitors») which have already been shown to be active
against the
target organism in the living pathogenic
cell as chemical leads for improvement by Medicinal Chemistry, towards systemically active Candidate Drugs.
They also identified
targets for potential therapies: bolstering levels of either a particular chaperone or a growth factor in brain
cells can protect
against the toxic effects of misfolded proteins.
Furthermore, niclosamide showed significant antitumor activity
against a panel of cervical cancer
cell lines via inhibition of mitochondrial respiration and the mammalian
target of rapamycin (mTOR) signaling pathway [42].
The discovery could prove to be a major asset in the fight
against several pathologies via the
targeting of a single immune
cell component.»
'» In all patients who were vaccinated, his team found tumor -
targeting T
cells, and he noted that in addition to augmenting pre-existing T
cell responses, the vaccine also stimulated new T
cell responses
against tumors.
Their findings on telomeres, the stretches of DNA at the ends of chromosomes that protect our genetic code and make it possible for
cells to divide, suggest a potential
target for preventive measures
against cancer, aging and other diseases.
Targeting inhibitory proteins within cytotoxic T
cells as a means to improve T
cell activity
against cancer has led to impressive clinical successes, but only in a minority of treated patients (1).
Enhanced phosphorylation of Nbs1, a member of DNA repair / checkpoint complex Mre11 - RAD50 - Nbs1, can be
targeted to increase the efficacy of imatinib mesylate
against BCR / ABL - positive leukemia
cells.
Our data suggests that
targeting DGKζ could prove to be a more useful clinical approach to augment cytotoxic T
cell activity
against tumor than
targeting Cbl - b, perhaps resulting from enhanced Ras / ERK signaling.
Once inside, the
cells could provoke an immune response that would confer immunity
against the
target viral protein.
Recently, interest has developed regarding the possibility of
targeting intracellular inhibitory proteins to improve T
cell activity
against cancer, including diacylglycerol kinase ζ (DGKζ)(9, 10) and Casitas b - lineage proto - oncogene b (Cbl - b)(11), which attenuate signal transduction events downstream of the TCR and CD28.
He said traditional drugs to treat tapeworm infection — which
target the whole organism at the larval stage - might not have been effective
against tapeworm cancer
cells, and it's also unclear whether chemotherapy for normal human cancer
cells could have helped shrink the tumors.
They were the first successful forms of immunotherapy for lymphoma, with rituximab (Rituxan), a monoclonal antibody
against the CD20
target, now the standard of care for all B
cell lymphomas.
His previous work at IDRI has included investigations into the physiology of the M.tuberculosis (Mtb)
cell wall, the development of an overexpression library for high throughput
target identification, and the development of
target based high throughput screens for potential drug candidates
against Mtb.
«If we can come up with strategies to carefully
target fat
cells, then I think activating this pathway could be effective in the fight
against obesity,» he says.
Low - dose chemotherapy, radiation, or
targeted therapies given in combination with immune checkpoint blockade may prove to be an effective and efficient way to immunize the body
against tumor
cells,» says CRI Scientific Advisory Council associate director James P. Allison, Ph.D., who identified the first immune checkpoint blockade with his discovery in 1995 that the cytotoxic T lymphocyte antigen - 4 (CTLA - 4) receptor inhibited T
cell responses.
T lymphocytes, or T
cells, are removed from patients» peripheral blood and reprogrammed with a gene, CAR, that when expressed actually redirects all of the T
cells against a single
target.
Next, we demonstrated the expression of PSCA and MUC1 in NSCLC, followed by the generation and confirmation of the specificity and efficacy of PSCA - and MUC1 -
targeting CAR T
cells against NSCLC
cell lines in vitro.
It is Dr. Chou's hope that, by treating colon cancer stem
cells with DAC and then exposing them to immune
cells that have been primed to recognize NY - ESO - 1, he can generate a
targeted and durable immune response
against these
cells without harming healthy
cells.
This customized library is screened
against the
target to detect binding or modulation of
target activity in biochemical or
cell - based assays.
In this system, the dendritic
cells are activated and
targeted against tumor
cells while remaining inside the patient's body.
Stephan's foggy early morning brainwave illuminated an unexpectedly simple approach to making
cell - based immunotherapy, in which cancer -
targeting immune
cells are enlisted to fight tumor
cells, as effective
against solid tumors as it has been
against blood cancers like leukemia.
Adults with advanced renal
cell carcinoma after
targeted therapy
against vascular endothelial growth factor (VEGF)
This study just found (in mice) that the common therapeutic
target for the anti-TNF medication treatment of IBD, may actually protect
against intestinal inflammation by inhibiting pathogenic T -
cells.
«We're using the whole tumor
cell, and that allows us to stimulate a response that's broad, that's
against multiple
targets, and that's
against targets that are unique to that individual patient,» Avigan said.
A pilot study demonstrated this combination elicited a powerful,
targeted immune response directed
against osteosarcoma
cells in patients suffering from this type of cancer.
One of their key modes of action is
targeted against microbial membranes and
cell walls, which are then disrupted by the higher frequiencies being generated.
In other words, when agents get a warrant to use a
cell - site simulator
against a suspect
target, and in doing so inevitably capture private phone information from countless innocent bystanders, the new policy still lets agents use that incidentally captured information
against those bystanders if they get court permission.